Pharmacokinetic interaction between indinavir and rifabutin

被引：0
|
作者：
Winchell, GA
McCrea, JB
Carides, A
Kusma, SE
Chiou, R
Deutsch, P
Yeh, KC
Waldman, S
Bjornsson, TD
机构：
[1] MERCK RES LABS,W POINT,PA 19486
[2] THOMAS JEFFERSON UNIV,PHILADELPHIA,PA 19107
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1997年 / 61卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：PI66 / PI66
页数：1
相关论文
共 50 条
  • [1] Steady-state pharmacokinetic interaction of modified-dose indinavir and rifabutin
    Hamzeh, FM
    Benson, C
    Gerber, J
    Currier, J
    McCrea, J
    Deutsch, P
    Ruan, P
    Wu, HL
    Lee, J
    Flexner, C
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (03) : 159 - 169
  • [2] Pharmacokinetic interaction between indinavir and rifampin
    McCrea, J
    Wyss, D
    Stone, J
    Carides, A
    Kusma, S
    Kleinbloesem, C
    AlHamdan, Y
    Yeh, K
    Deutsch, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PI62 - PI62
  • [3] A pharmacokinetic interaction between omeprazole and indinavir was suggested
    Reactions Weekly, 1998, 732 (1) : 5 - 5
  • [4] Pharmacokinetic interaction between ritonavir and indinavir in healthy volunteers
    Hsu, A
    Granneman, GR
    Cao, GL
    Carothers, L
    Japour, A
    El-Shourbagy, T
    Dennis, S
    Berg, J
    Erdman, K
    Leonard, JM
    Sun, EG
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (11) : 2784 - 2791
  • [5] Lack of a pharmacokinetic interaction between indinavir and methadone.
    Cantilena, L
    McCrea, J
    Blazes, D
    Winchell, G
    Carides, A
    Royce, C
    Deutsch, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 135 - 135
  • [6] Pharmacokinetic interaction between atovaquone suspension (ATVQ) and rifabutin (RFB).
    Gillotin, C
    Grandpierre, I
    Sadler, BM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 229 - 229
  • [7] Pharmacokinetic interaction between amprenavir and rifabutin or rifampin in healthy males
    Polk, RE
    Brophy, DF
    Israel, DS
    Patron, R
    Sadler, BM
    Chittick, GE
    Symonds, WT
    Lou, Y
    Kristoff, D
    Stein, DS
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) : 502 - 508
  • [8] Pharmacokinetic interaction between fosamprenavir-ritonavir and rifabutin in healthy subjects
    Ford, Susan L.
    Chen, Ya-Chi
    Lou, Yu
    Borland, Julie
    Min, Sherene S.
    Yuen, Geoffrey J.
    Shelton, Mark J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (02) : 534 - 538
  • [9] Drug-drug interaction between rifabutin and dolutegravir: A population pharmacokinetic model
    Kawuma, Aida N. N.
    Wasmann, Roeland E. E.
    Dooley, Kelly E. E.
    Maartens, Gary
    Denti, Paolo
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (03) : 1216 - 1221
  • [10] Pharmacokinetic interaction between the proton pump inhibitor omeprazole and the HIV protease inhibitor indinavir
    Burger, DM
    Hugen, PWH
    Kroon, FP
    Groeneveld, P
    Brinkman, K
    Foudraine, NA
    Sprenger, H
    Koopmans, PP
    Hekster, YA
    AIDS, 1998, 12 (15) : 2080 - 2082
12345